Icon (ICLR) Common Equity (2009 - 2026)
Icon's (ICLR) quarterly Common Equity came in at $9.4 billion in Q2 2026, down 1.29% year-over-year from $9.5 billion in Q2 2025, and up 0.84% quarter-over-quarter from $9.3 billion in Q1 2026.
Analysis
Icon (ICLR) Common Equity (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Common Equity for 18 consecutive years, with $9.4 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Common Equity fell 1.29% year-over-year to $9.4 billion in Q2 2026; TTM through Jun 2026 was $9.4 billion, a 1.29% decrease from a year earlier, with the FY2025 full-year figure at $9.2 billion, down 3.24% from the prior year.
- Common Equity was $9.4 billion for Q2 2026 at Icon, up from $9.3 billion in the prior quarter.
- Over five years, Common Equity peaked at $9.8 billion in Q3 2024 and troughed at $8.1 billion in Q1 2022.
- A 5-year average of $9.1 billion and a median of $9.3 billion in 2023 frame the typical range for Common Equity.
- Across the five-year window, Common Equity jumped 317.2% in 2022 and dropped 4.5% in 2025, its largest moves.
- Over 5 years, Common Equity stood at $8.5 billion in 2022, then climbed by 8.03% to $9.2 billion in 2023, then grew by 3.14% to $9.5 billion in 2024, then fell by 3.24% to $9.2 billion in 2025, then climbed by 2.01% to $9.4 billion in 2026.
- The last three Common Equity figures came in at $9.4 billion (Q2 2026), $9.3 billion (Q1 2026), and $9.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 6.30 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 433.86 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 9.38 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 2.85 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 524.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 773.64 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 420.28 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 4.46 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 4.96 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -2.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.38 Bn |
| Mar 31, 2026 | 9.30 Bn |
| Dec 31, 2025 | 9.19 Bn |
| Sep 30, 2025 | 9.33 Bn |
| Jun 30, 2025 | 9.50 Bn |
| Mar 31, 2025 | 9.43 Bn |
| Dec 31, 2024 | 9.50 Bn |
| Sep 30, 2024 | 9.77 Bn |
| Jun 30, 2024 | 9.59 Bn |
| Mar 31, 2024 | 9.43 Bn |
| Dec 31, 2023 | 9.21 Bn |
| Sep 30, 2023 | 8.96 Bn |
| Jun 30, 2023 | 8.80 Bn |
| Mar 31, 2023 | 8.65 Bn |
| Dec 31, 2022 | 8.53 Bn |
| Sep 30, 2022 | 8.24 Bn |
| Jun 30, 2022 | 8.15 Bn |
| Mar 31, 2022 | 8.07 Bn |
| Dec 31, 2021 | 8.07 Bn |
| Sep 30, 2021 | 7.97 Bn |